Single arm:Rituximab

2 trials

Sponsors

The First Affiliated Hospital, Sun Yat-Sen University

Conditions

Difficult-to-treat nephropathy syndromeidiopathic membranous nephropathy

Phase 4

Prospective study of rituximab combined with low-dose hormone in the treatment of idiopathic membranous nephropathy

RecruitingChiCTR2000040799

The First Affiliated Hospital, Sun Yat-Sen Universityidiopathic membranous nephropathy

Start: 2020-05-20Updated: 2021-04-12

Prospective cohort study of rituximab combined with low dose hormone in the treatment of refractory nephrotic syndrome

RecruitingChiCTR2100046611

The First Affiliated Hospital, Sun Yat-Sen UniversityDifficult-to-treat nephropathy syndrome

Start: 2021-01-20Updated: 2022-01-04